Alnylam Cambridge, MA

Drug development focused on the novel mechanism of RNA interference - IPO 5/27/04

Momenta Pharmaceuticals, Inc. Cambridge, MA

Development of novel therapeutics through the innovation and application of glycomics - IPO 6/21/04

aTyr Pharma, Inc.San Diego, CA

Biopharmaceutical Company developing novel protein biologics for regenerative medicine.

Rib-X New Haven, CT

A Bioscience company focused of the discovery of new anti-infectives

Cubist Pharmaceuticals Cambridge, MA

Pharmaceutical Company Developing Novel Antimicrobial Drugs

Sirtris Pharmaceuticals Boston, MA

Discovery and development of novel therapeutics to treat diabetes, obesity and other metabolic diseases.